Abstract
Adaptive Pathways (AP) has been proposed as a exible regularization approach for the Con-
ditional Approval (CA) of drugs targeting an unmet medical need, especially rare diseases. AP
allows for early approval based on a more limited amount of data, on the condition that addi-
tional post-approval evidence is collected by the sponsor.
... read more